Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.020
+0.010 (0.99%)
At close: Jun 26, 2026, 4:00 PM EDT
1.000
-0.020 (-1.97%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Cocrystal Pharma Employees
Cocrystal Pharma had 10 employees as of December 31, 2025. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
$22,500
Profits / Employee
-$882,900
Market Cap
14.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| BioLineRx | 24 |
| Citius Pharmaceuticals | 23 |
| IN8bio | 18 |
| Atossa Therapeutics | 16 |
| BioVie | 13 |
| Lexaria Bioscience | 7 |
| Traws Pharma | 7 |
COCP News
- 25 days ago - Cocrystal co-CEOs Sam Lee and Jim Martin step down, James Sapirstein succeeds - TheFly
- 25 days ago - Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer - GlobeNewsWire
- 4 weeks ago - Cocrystal Pharma announces discovery of pan-viral inhibitors targeting viruses - TheFly
- 4 weeks ago - Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza - GlobeNewsWire
- 6 weeks ago - Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 2 months ago - Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection - GlobeNewsWire
- 2 months ago - Cocrystal Pharma files $150M mixed securities shelf - TheFly
- 3 months ago - Cocrystal Pharma receives FDA Fast Track designation for CDI-988 - TheFly